Agios Pharmaceuticals Inc. (AGIO)
NASDAQ · Healthcare
Agios Pharmaceuticals Inc. Total Liabilities 2011–2025
Agios Pharmaceuticals Inc. annual total liabilities history from 2016 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Agios Pharmaceuticals Inc. total liabilities as of December 31, 2025: 104.1M, a 14.83% decrease year-over-year.
- Agios Pharmaceuticals Inc. total liabilities for 2025 were 104.1M, a 14.83% decrease from 2024.
- Agios Pharmaceuticals Inc. total liabilities for 2024 were 122.2M, a 3.06% decrease from 2023.
- Agios Pharmaceuticals Inc. total liabilities for 2023 were 126.1M, a 8.56% decrease from 2022.
- Agios Pharmaceuticals Inc. total liabilities for 2022 were 137.9M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Agios Pharmaceuticals Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $104 |
| 2024 | $122 |
| 2023 | $126 |
| 2022 | $138 |
| 2021 | $146 |
| 2020 | $453 |
| 2019 | $250 |
| 2018 | $171 |
| 2017 | $239 |
| 2016 | $261 |
Agios Pharmaceuticals Inc. Total Liabilities — FAQ
Agios Pharmaceuticals Inc. (AGIO) total liabilities over the last 15 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AGIO's total liabilities history?
The chart and table above show Agios Pharmaceuticals Inc.'s total liabilities by year and by quarter, including the growth rate.